| A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed (NCT05422326) | Seqirus | 2022-07-18 |
| Integrating Enhanced HIV PrEP Into a STI Clinic in Lilongwe (NCT05307991) | University of North Carolina, Chapel Hill | 2022-03-09 |
| EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19 (NCT04822818) | Assistance Publique - Hôpitaux de Paris | 2021-04-17 |
| Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19) (NCT04664075) | Imperial College London | 2021-01-25 |
| A Phase III Clinical Study to Evaluate SYN023's Efficacy and Safety (NCT04644484) | Synermore Biologics (Suzhou) Co., Ltd. | 2020-09-23 |
| Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 (NCT04365101) | Celularity Incorporated | 2020-09-02 |
| Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19 (NCT04476979) | Assistance Publique - Hôpitaux de Paris | 2020-07-16 |
| Prevalence and Risk Factors of COVID-19 in the Upper Silesian Agglomeration (NCT04627623) | Medical University of Silesia | 2020-06-22 |
| COVID-19 and SARS-CoV-2 Detection in Saliva (NCT04517682) | Ambry Genetics | 2020-05-21 |
| ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19 (NCT04367740) | University of North Carolina, Chapel Hill | 2020-04-28 |
| A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised Adults (NCT04380701) | BioNTech SE | 2020-04-23 |
| Convalescent Plasma Collection and Treatment in Pediatrics and Adults (NCT04376034) | West Virginia University | 2020-04-16 |
| Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination (NCT03776760) | Kirby Institute | 2019-05-28 |
| Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly (NCT03739112) | Medicago | 2018-09-18 |
| Venezuelan Equine Encephalitis Monovalent Virus-Like Particle Vaccine (NCT03776994) | SRI International | 2018-07-17 |
| Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018) (NCT03392207) | Butantan Institute | 2018-04-23 |
| Centralized Reminder Recall - Flu RCT2 (NCT03294473) | University of California, Los Angeles | 2017-10-18 |
| Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults (NCT03301051) | Medicago | 2017-08-31 |
| VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents (NCT03110770) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-03-29 |
| DNA and RNA Viruses of the Blood Virome of Allogeneic Hematopoietic Stem Cell Transplant Recipients (NCT03642977) | University Hospital, Geneva | 2017-03-01 |
| Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults (NCT02831751) | Medicago | 2016-04-01 |
| Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy Adults (NCT02768805) | Medicago | 2016-03-02 |
| Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021) (NCT02613403) | Merck Sharp & Dohme LLC | 2015-12-10 |
| Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults (NCT02233816) | Medicago | 2014-07-28 |
| Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly Population (NCT02236052) | Medicago | 2014-07-16 |
| Vitamin D and Vitamin B12 Supplementation With Pegylated Interferon-Alfa Plus Ribavirin for Treating Chronic Hepatitis C (NCT02120274) | Federal University of São Paulo | 2014-03-01 |
| Safety, Tolerability and Immunogenicity of a Plant-made H7 Virus-like Particle (VLP) Influenza Vaccine in Adults. (NCT02022163) | Medicago | 2013-12-01 |
| Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults (NCT01991587) | Medicago | 2013-10-08 |
| Immunogenicity, Safety, Tolerability of a Plant-made H5 Virus-like-particle (VLP) Influenza Vaccine. (NCT01991561) | Medicago | 2013-06-01 |
| DNA-based Influenza Vaccine in the Elderly (NCT01587131) | University of Manitoba | 2012-06-01 |
| Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru (NCT02630082) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-04-01 |
| Immunogenicity, Safety, Tolerability of a Plant-Made H5 VLP Influenza Vaccine (NCT01244867) | Medicago | 2010-11-01 |
| Clinic-based ART Diagnostic Evaluation (NCT01791556) | Walter Reed Army Institute of Research (WRAIR) | 2010-01-26 |
| Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults (NCT00984945) | Medicago | 2009-09-01 |
| Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and Tuberculosis (NCT05065905) | SPP Pharmaclon Ltd. | 2006-01-19 |